Revolution Medicines, Inc.
RVMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,837,088 | $6,921,888 | $6,652,843 | $7,336,846 |
| - Cash | $217,442 | $402,438 | $333,554 | $543,064 |
| + Debt | $158,461 | $132,787 | $134,342 | $135,843 |
| Enterprise Value | $8,778,107 | $6,652,237 | $6,453,631 | $6,929,625 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$289,440 | -$260,912 | -$237,044 | -$212,923 |
| % Margin | – | – | – | – |
| Net Income | -$305,206 | -$247,787 | -$213,416 | -$194,569 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.61 | -1.31 | -1.13 | -1.13 |
| % Growth | -22.9% | -15.9% | 0% | – |
| Operating Cash Flow | -$207,311 | -$221,757 | -$194,435 | -$138,290 |
| Capital Expenditures | -$3,349 | -$7,450 | -$3,266 | -$1,222 |
| Free Cash Flow | -$210,660 | -$229,207 | -$197,701 | -$139,512 |